2m 2m 2m 2m 2m 2m 2m
CG ONCOLOGY (CGON)
NASDAQ
$72.40-$0.10 (-0.14%)
Price as of Jul 13, 2026 7:49 PM EDT- $6.6BMarket Cap
- 179.92%1-Year Change
- BiotechnologyIndustry
CG ONCOLOGY (CGON)
$72.40-$0.10 (-0.14%)
CGON | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $72.50 | ||
Change | -$2.74 (-3.64%) | ||
Open | $74.75 | ||
High | $74.75 | ||
Low | $70.72 | ||
Previous Close | $75.24 | ||
Volume | 992,454 | ||
30-Day Average Volume | 1,296,155 | ||
1-Week Change | 4.68% | ||
1-Month Change | 21.73% | ||
1-Year Change | 179.92% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 88.2M | ||
Total Assets | $1.1B | ||
Market Cap | $6.6B | ||
Enterprise Value | $6.6B | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$60.2M | ||
Free Cash Flow | -$57.2M | ||
EBIT | -$60.2M | ||
EBITDA | -$59.4M | ||
Net Working Capital | $1.1B | ||
EPS | -$0.71 | ||
Enterprise Value/EBITDA | -111 | ||
Enterprise Value/Revenue | 6,179 | ||
P/B | 6 | ||
P/E | -106 | ||
PEG | 3 | ||
Price/Free Cash Flow | -116 | ||
Price/Operating Cash Flow | -117 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue